The final word and ‘smoking gun’ documents – ACCC v Pfizer

For those readers interested in the issues surrounding competitive moves by pharmaceutical companies in the scenario where a key patent comes to an end, we report on the recent decision of the Full Federal Court in the ACCC v Pfizer matter here: ACCC v Pfizer – KWM News & Insights

About the Author

Veg TranVeg is a Special Counsel in the Sydney IP - Dispute Resolution team. When she is not satisfying her addiction to "true crime" television shows and following the NHL hockey season, Veg enjoys pursuing her morbid curiosity in patent law. Armed with her formative training in biotechnology, Veg dedicates many of her working hours reviewing gruesome patent specifications and advising clients in a wide range of life science sectors.View all posts by Veg Tran